Dr Matthew Frigault, Instructor and Clinical Assistant in Medicine at Massachusetts General Hospital, gives the clinician’s perspective on patient access and delivery of advanced therapies and answers four crucial questions:
- Are specific centres of excellence the answer to improving patient access to advanced therapies and clinical trials?
- Is the next generation of cellular immunotherapies agnostic?
- Can you share some of the cellular immunotherapy initiatives going on at Mass General Cancer Center?
- What role, if any, can clinicians play in working with payers to secure funding for ATMPs?